人工臓器の世界市場2021年-2025年

◆英語タイトル:Global Artificial Organs Market 2021-2025
◆商品コード:IRTNTR44011
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年5月25日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は、人工臓器の世界市場規模が2021年から2025年まで年平均約9%成長し、109.0億ドルに達すると予測しています。本調査資料では世界の人工臓器市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(人工心臓、人工腎臓、人工内耳、人工膵臓)分析、顧客状況、地域別状況、企業状況、企業分析など、以下の項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・人工臓器の世界市場規模:製品別(人工心臓、人工腎臓、人工内耳、人工膵臓)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Artificial Organs Market 2021-2025

Technavio has been monitoring the artificial organs market and it is poised to grow by $ 10.90 billion during 2021-2025, progressing at a CAGR of almost 9% during the forecast period. Our report on the artificial organs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders and the shortage of organ donors. In addition, the increasing prevalence of chronic disorders is anticipated to boost the growth of the market as well.

The artificial organs market analysis includes the product segment and geographic landscape.
Technavio’s artificial organs market is segmented as below:

By Product
• Artificial heart
• Artificial kidney
• Cochlear implants
• Artificial pancreas

By Geography
• North America
• Europe
• Asia
• ROW

This study identifies the growing demand for pacemakers and dialyzersas one of the prime reasons driving the artificial organs market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on artificial organs market covers the following areas:
• Artificial organs market sizing
• Artificial organs market forecast
• Artificial organs market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial organs market vendors that include Abbott Laboratories, Asahi Kasei Corp., B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Medtronic Plc, and Nipro Europe Group Companies. Also, the artificial organs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/artificial-organs-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Artificial heart – Market size and forecast 2020-2025
o Artificial kidney – Market size and forecast 2020-2025
o Cochlear implants – Market size and forecast 2020-2025
o Artificial pancreas – Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Asahi Kasei Corp.
o B. Braun Melsungen AG
o Baxter International Inc.
o Boston Scientific Corp.
o Cochlear Ltd.
o F. Hoffmann-La Roche Ltd.
o Fresenius Medical Care AG and Co. KGaA
o Medtronic Plc
o Nipro Europe Group Companies
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Product – Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Artificial heart – Market size and forecast 2020-2025 ($ million)
• 24: Artificial heart – Year-over-year growth 2020-2025 (%)
• 25: Artificial kidney – Market size and forecast 2020-2025 ($ million)
• 26: Artificial kidney – Year-over-year growth 2020-2025 (%)
• 27: Cochlear implants – Market size and forecast 2020-2025 ($ million)
• 28: Cochlear implants – Year-over-year growth 2020-2025 (%)
• 29: Artificial pancreas – Market size and forecast 2020-2025 ($ million)
• 30: Artificial pancreas – Year-over-year growth 2020-2025 (%)
• 31: Market opportunity by Product
• 32: Customer landscape
• 33: Market share by geography 2020-2025 (%)
• 34: Geographic comparison
• 35: North America – Market size and forecast 2020-2025 ($ million)
• 36: North America – Year-over-year growth 2020-2025 (%)
• 37: Europe – Market size and forecast 2020-2025 ($ million)
• 38: Europe – Year-over-year growth 2020-2025 (%)
• 39: Asia – Market size and forecast 2020-2025 ($ million)
• 40: Asia – Year-over-year growth 2020-2025 (%)
• 41: ROW – Market size and forecast 2020-2025 ($ million)
• 42: ROW – Year-over-year growth 2020-2025 (%)
• 43: Key leading countries
• 44: Market opportunity by geography ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: Abbott Laboratories – Overview
• 52: Abbott Laboratories – Business segments
• 53: Abbott Laboratories – Key offerings
• 54: Abbott Laboratories – Key customers
• 55: Abbott Laboratories – Segment focus
• 56: Asahi Kasei Corp. – Overview
• 57: Asahi Kasei Corp. – Business segments
• 58: Asahi Kasei Corp. – Key offerings
• 59: Asahi Kasei Corp. – Key customers
• 60: Asahi Kasei Corp. – Segment focus
• 61: B. Braun Melsungen AG – Overview
• 62: B. Braun Melsungen AG – Business segments
• 63: B. Braun Melsungen AG – Key offerings
• 64: B. Braun Melsungen AG – Key customers
• 65: B. Braun Melsungen AG – Segment focus
• 66: Baxter International Inc. – Overview
• 67: Baxter International Inc. – Business segments
• 68: Baxter International Inc. – Key offerings
• 69: Baxter International Inc. – Key customers
• 70: Baxter International Inc. – Segment focus
• 71: Boston Scientific Corp. – Overview
• 72: Boston Scientific Corp. – Business segments
• 73: Boston Scientific Corp. – Key offerings
• 74: Boston Scientific Corp. – Key customers
• 75: Boston Scientific Corp. – Segment focus
• 76: Cochlear Ltd. – Overview
• 77: Cochlear Ltd. – Business segments
• 78: Cochlear Ltd. – Key offerings
• 79: Cochlear Ltd. – Key customers
• 80: Cochlear Ltd. – Segment focus
• 81: F. Hoffmann-La Roche Ltd. – Overview
• 82: F. Hoffmann-La Roche Ltd. – Business segments
• 83: F. Hoffmann-La Roche Ltd. – Key offerings
• 84: F. Hoffmann-La Roche Ltd. – Key customers
• 85: F. Hoffmann-La Roche Ltd. – Segment focus
• 86: Fresenius Medical Care AG and Co. KGaA – Overview
• 87: Fresenius Medical Care AG and Co. KGaA – Business segments
• 88: Fresenius Medical Care AG and Co. KGaA – Key offerings
• 89: Fresenius Medical Care AG and Co. KGaA – Key customers
• 90: Fresenius Medical Care AG and Co. KGaA – Segment focus
• 91: Medtronic Plc – Overview
• 92: Medtronic Plc – Business segments
• 93: Medtronic Plc – Key offerings
• 94: Medtronic Plc – Key customers
• 95: Medtronic Plc – Segment focus
• 96: Nipro Europe Group Companies – Overview
• 97: Nipro Europe Group Companies – Product and service
• 98: Nipro Europe Group Companies – Key offerings
• 99: Nipro Europe Group Companies – Key customers
• 100: Nipro Europe Group Companies – Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations



【掲載企業】

Abbott Laboratories, Asahi Kasei Corp., B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Medtronic Plc, Nipro Europe Group Companies

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[人工臓器の世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆